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Erucylphosphocholine, an alkylphosphocholine anticancer drug, was employed for Langmuir monolayer
characterization and liquid crystalline studies. Differential scanning calorimetry measurements together with
texture observation with polarizing microscope revealed the presence of nematic phase. Film forming properties
of erucylphosphocholine at the air/water interface were thoroughly investigated by means of surface pressure–area
(pi–A) and electric surface potential–area (∆V –A) isotherms. The influence of such factors as subphase temper-
ature, ionic strength, speed of compression, number of molecules spread at the surface on the characteristics of
the pi–A isotherms was investigated. Erucylphosphocholine was found to form very stable Langmuir monolayers,
which are almost not influenced by experimental conditions. The liquid character of its monolayers was confirmed
with both compressibility modulus values and homogeneous Brewster angle microscopy images.
PACS: 68.18.−g
1. Introduction
Phospholipids that constitute cell membranes of mam-
mals, i.e. glycerophospholipids (Fig. 1a) and sphin-
gophospholipids, play a very important role in cell func-
tion and development, in addition to their structural
function and molecular recognition [1]. The replacement
of natural phospholipids by their synthetic, structurally
modified analogues has resulted in significant changes in
cell function. This has been the starting point for a
new line of research in the treatment of various diseases.
In this way, a new group of substances that are useful
as anticancer drugs, known as antitumor lipids (ATLs),
has been created. Their synthesis was inspired by the
properties found for lysophosphatidylcholines — LPCs
(Fig. 1b), which occur in natural membranes as an inter-
mediate product of phosphatidylcholine metabolism [2].
Interestingly these compounds, having detergent activity,
were found to cause cell lysis and affect the fluidity and
permeability of biological membranes [3, 4]. Taking these
properties into account, structural analogues of LPCs
were synthesized, in which easily hydrolysable ester bond
at the C1 carbon has been replaced by ether moiety, while
the hydroxyl group at the C2 carbon was esterified with a
small alkyl substituent (methyl or ethyl). Such molecules
were called alkyl-lysophospholipids — ALPs (Fig. 1c).
Although they are structurally similar to LPCs, their sta-
bility was significantly improved by the chemical modifi-
cation. Moreover, due to differences in functional groups,
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they are stable in vivo in contrast to natural phospho-
lipids, which can be easily metabolized. Interestingly,
ALPs were proved to show cytostatic and cytotoxic activ-
ity on certain tumor cells. In addition, these compounds
have important biological functions, among which the in-
duction of cell maturation and apoptosis (programmed
cell suicide) should be emphasized, in addition to the in-
hibition of tumor cell invasion [5]. The most effective
drug of the ALPs series is edelfosine (1-O-octadecyl-2-
-O-methyl-rac-glycero-3-phosphocholine, in short Et-18-
-OCH3) [6].
Fig. 1. Chemical formulae of the natural phospholipids
and their synthetic analogues. General chemical struc-
ture of (A) glycerophospholipid, (B) lysophosphatidyl-
choline (LPC), (C) alkyl lysophospholipid (ALP),
(D) alkylphosphocholine (APC).
In search of new derivatives of simpler chemical struc-
ture, exhibiting similar physiological properties as the
ALPs, lipid ethers were synthesized, which do not have
the glycerol backbone in their structure (Fig. 1d). They
were called alkylphosphocholines (APCs). Such a simpli-
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fication of the structure was originated by Eibl and co-
-workers from the Max Planck Institute in Göttingen [7].
Their research led to synthesis of the first alkylphos-
phocholine possessing C16 alkyl chain (R1) (Fig. 1d) —
miltefosine (hexadecylophosphocholine, HePC, C16PC)
— [8], which was approved (under the name of Mil-
tex) for the topical treatment of metastatic breast can-
cer and skin. Another products of this group include its
longer homologues — octadecylphosphocholine (OcPC,
C18PC), with C18 hydrocarbon tail (R1) and erucylphos-
phocholine, ErPC (Fig. 2), the latter having 22-carbon
hydrocarbon chain and double cis bond between 13 and
14 carbon atoms [9–11].
Fig. 2. Chemical structure of erucylphosphocholine
(ErPC).
The absence of glycerol unit in the molecule is of
great biological importance, since while natural phospho-
lipids are metabolized easily by different phospholipases,
such as A1, A2, C and D, the resulting alkyl ether-type
molecules are not susceptible to such enzymes. This
means significant advantages of these substances when
used for the purpose of drugs. Similarly to phospholipids,
they are surface-active [12], which results from their am-
phiphilic character (the presence of two opposing frag-
ments within a molecule — a hydrophobic chain and a
hydrophilic group). This property facilitates the affin-
ity of such molecules to biomembranes. Indeed, cellular
membrane was assigned to be the primarily site of action
for both ALPs and APCs [13, 14], contrary to traditional
cytotoxic agents applied in chemotherapy (e.g. cisplatin
or vinblastine), which are known to target DNA [6, 15].
Apart from many studies, the exact mode of action and
the mechanism of selectivity of ATLs are still not clear.
In order to get insight into these issues, studies on molec-
ular interactions between the drug and membrane com-
ponents are of utmost importance. To reach this goal,
the Langmuir monolayer technique [16], which serves as
a very useful, easy to handle and controllable model of
biomembranes [17], can be employed. However, the re-
quirement for using this technique is that the molecule
of interest must be surface active and possess the ability
of stable Langmuir monolayer formation.
Therefore, the aim of this paper is to check the capa-
bility of forming Langmuir monolayers by erucylphospho-
choline — one of the newest alkylphosphocholines, having
the advantage over HePC and OcPC of being suitable
for intravenous administration, thus showing improved
anticancer activity with reduced hemolytic and gastroin-
testinal side effects [18]. Anticancer activity of ErPC has
already been confirmed both in vivo and in vitro models.
Because ErPC is able to cross blood–brain barrier [10],
therefore it can be effectively applied for glioblastoma
therapy, inducing apoptosis in chemo- and radiation re-
sistant glioma cell lines [10, 19, 20]. Effective anticancer
action of this drug was also confirmed on hepatocellular
liver carcinoma cell lines [21], endometrial and ovarian
cancer cells [22], lymphoma [9] and leukemia cell lines as
well as on methylnitrosurea induced mamma carcinoma
of the rat in vivo [23].
Our results confirm that ErPC is capable of stable
Langmuir monolayers formation and is a suitable mate-
rial for subsequent studies with the Langmuir technique.
We do expect that further systematic studies on interac-
tions between ErPC and membrane components may be
of much help in getting insight into the way how the drug
can selectively be targeted to the tumor cell membrane,
sparing the normal cells. This will be a subject of our
future articles.
2. Experimental
Anhydrous erucylphosphocholine was kindly supplied
by Aeterna Zentaris GmbH (Frankfurt, Germany). The
compound was kept in the freezer in an evacuated dessi-
cator in the presence of anhydrous calcium chloride as
a strongly hydroscopic medium. The spreading solution
for the Langmuir experiments was prepared by dissolv-
ing the investigated compound in a chloroform:methanol
(Sigma-Aldrich, p.a.)(9:1 v/v) mixture with a typical
concentration of ca. 0.2–0.5 mg/mL. The spreading so-
lution was dropped onto the surface of ultrapure water
(produced by a Nanopure water purification system cou-
pled to a Milli-Q water purification system, resistivity =
18.2 MΩ cm) with a Microman Gilson microsyringe,
precise to ±0.2 µL. In routine experiments 4.54 × 1016
molecules were spread at the water surface of pH 5.6 and
T = 20 ◦C. The subphase temperature was controlled
to within 0.1 ◦C by a circulating water system from Ju-
labo. The ionic strength of the subphase was adjusted
by addition of NaCl (Merck, p.a.). To study the influ-
ence of subphase pH, the spreading solution was dropped
onto the Theorell–Stenhagen buffer subphase [24] (ionic
strength < 0.1), which was prepared with ultrapure wa-
ter. The pH of aqueous subphases was measured with
an Elmetron CX-731 pH meter. Experiments were car-
ried out on a Langmuir trough (total area = 600 cm2)
placed on an antivibration table. Surface pressure was
measured with the accuracy of ±0.1 mN/m using a Wil-
helmy plate made from chromatography paper (What-
man Chr1) as the pressure sensor. After spreading, the
monolayers were left for 10 min for the solvent to evap-
orate, after which compression was initiated with a bar-
rier speed of 50 cm2/min, unless otherwise specified. The
monolayer stability was verified by monitoring the change
in area while holding the surface pressure constant. Each
isotherm was repeated at least three times to ensure re-
producibility of the curves to ±2 Å2.
Surface potential measurements were performed with
the Kelvin probe (model KP2, NFT, Germany) mounted
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on a NIMA trough. The vibrating plate was located ca.
2 mm above the water surface while the reference elec-
trode, made from platinum foil, was placed in the water
subphase. The surface potential measurements were re-
producible to ±10 mV. Both surface pressure–area and
electric surface potential–area isotherms reported here
are the averages of at least three experiments.
The Brewster angle microscopy (BAM) experiments
were performed with ultraBAM instrument (Accurion
GmbH, Goettingen, Germany) equipped with a 50 mW
laser emitting p-polarized light at a wavelength of
658 nm, a 10× magnification objective, polarizer, ana-
lyzer and a CCD camera. The spatial resolution of the
BAM was 2 µm.
Differential scanning calorimetry (DSC) measurements
were done with Perkin Elmer Diamond 6000 DSC
calorimeter. The calorimeter was calibrated by means
of the melting points of indium and water. The highly
pure nitrogen and helium was used during measurements.
The sample was placed in an aluminium pans. The mass
of the sample used was equal to ca. 7 mg. Three scans
(heating and cooling) was done for the compound stud-
ied. The heating and cooling rates of all scans were equal
to ±10 K/min.
The polarizing microscope Nikon Eclipse equipped
with Linkam heating stage was used for texture obser-
vations. The configuration of crossed polarizers was ap-
plied. The liquid nitrogen was used to stabilize the heat-
ing and cooling rates, which were equal to ±5 K/min.
The texture of the phases appearing during heating and
cooling of the sample was registered by the digital camera
connected with the microscope. The change in the tex-
ture with temperature means change in the phase. There-
fore based on the texture observation one can conclude
about the transition temperature between the phases
detected.
3. Results and discussion
The surface pressure–area (pi/A) isotherm of
erucylphosphocholine spread on water (pH 5.6, 20 ◦C)
is shown in Fig. 3, which also contains the compression
modulus, C−1s (defined as C−1s = −Adpi/dA) vs. surface
pressure (pi) dependence (inset of Fig. 3). The isotherm
starts to rise at about 90 Å2/molecule. The course of the
isotherm indicates a liquid (L) state of the monolayer.
Upon compression, the surface pressure raises mono-
tonically until film collapse, which occurs slightly above
40 mN/m. The state of erucylphosphocholine monolayer
can be quantified with the compression modulus values,
reaching maximum value of ca. 80 mN/m, which meets
the criterion of a liquid character [25]. This is confirmed
with homogeneous BAM images throughout the whole
compression. From the isotherm it can be seen that the
limiting area of the molecule at the surface is ca. 75 Å2.
This value suggests that the limiting area is determined
by the dimension of the molecule head group, i.e. phos-
phocholine. Such an interpretation can be supported by
the fact that the limiting area of other APC homologues
differing in the hydrophobic part structure (e.g. hexade-
cylphosphocholine [26] and octadecylphosphocholine)
are very similar to erucylphosphocholine.
Fig. 3. Surface pressure (pi)–area (A) isotherms of
erucylphosphocholine monolayer spread on water to-
gether with BAM images. Inset — compression modu-
lus (C−1s )–pi dependence. Subphase temperature: 20 ◦C.
In order to provide a detailed Langmuir monolayer
characterization of erucylphosphocholine, monolayer ex-
periments under different subphase conditions were per-
formed, as described below.
In a set of control experiments, we observed that
changing the number of molecules deposited on the sur-
face did not influence the isotherms for this compound
(see Fig. 4a). Secondly, the variation in compression
speed from 50 to 100 cm2/min does not influence the
isotherm, however, with a lower speed of the isotherm
(20 cm2/min) a slight shift is observed towards lower ar-
eas (Fig. 4b). This may indicate a partial loss of film-
-forming molecules from the surface when the compres-
sion speed was significantly decreased. Indeed, upon
leaving a monolayer on water subphase for 5, 10 or 25 min
before the compression was initiated, a small shift to-
wards lower areas is observed upon increasing the time
(Fig. 4c), which confirms the previous result.
The influence of subphase temperature on erucylphos-
phocholine monolayers has also been studied. Fig-
ure 4d indicates that the change in subphase temperature
within the range of 20–30 ◦C practically did not alter the
isotherms. Only at lower subphase temperature (10 ◦C)
the isotherm is slightly shifted towards smaller areas,
however, it is practically parallel to the others recorded
at higher temperatures. As a result, the compression
modulus–surface pressure curves for all the investigated
temperatures superimpose, indicating that the subphase
temperature has no effect on monolayer packing. The
only parameter that changes with temperature is the
collapse pressure — the highest (43 mN/m) is reached
at the lowest investigated temperature, while the lowest
(41 mN/m) at 30 ◦C.
Figure 4e shows the isotherms obtained on aqueous
subphases of different pH at 20 ◦C. As it can be seen, the
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Fig. 4. The influence of experimental conditions on the
pi-area isotherms of erucylphosphocholine — description
in the text.
change of subphase pH within the range of 3–9 has prac-
tically no influence on the isotherms. This indicates that
erucylphosphocholine exists in the form of zwitterions at
these pH values.
From these studies it is evident that changing sub-
phase and compression conditions does not modify
significantly the characteristics of monolayers from
erucylphoshocholine. Therefore we may conclude that
ErPC forms stable Langmuir monolayers at air/aqueous
solution interface. To get a further evidence on its sta-
bility, the experiment was performed in which the mono-
layer was first compressed until the desired surface pres-
sure value (10, 20, and 30 mN/m), which was afterwards
kept constant, and the decrease in area was monitored
with time (Fig. 5). As it can be seen, no area loss was
observed with time, which is another proof of the film
stability.
To get insight into the behavior of erucylphospho-
choline spread at the air/water interface, the change of
surface potential (∆V ) vs. molecular area was recorded
simultaneously with the pi–A isotherms and the obtained
results are presented in Fig. 6. Generally, the surface
potential starts to change at slightly larger areas than
the surface pressure, which is usually observed for film-
-forming molecules [27]. Upon compression, the sur-
face potential rises gradually, reaching maximum (of ca.
180 mV), which is achieved at the molecular area sim-
ilar to that of the film collapse. We have applied the
Helmholtz model of a Langmuir monolayer [28] to calcu-
late the apparent dipole moment of erucylphosphocholine
at the air/water interface. According to this model,
Fig. 5. Static stability experiments of erucylphospho-
choline monolayer — description in the text.
∆V =
µ⊥
Aεε0
, (1)
where µ⊥ is the vertical component of the dipole moment
(so-called effective dipole moment), A is molecular area,
ε is the electrical permittivity of a monolayer, and ε0 is
the electrical permittivity of vacuum. Because ε values
are unknown and are not constant upon film compres-
sion [28], therefore so-called apparent dipole moment is
introduced and defined as: µA = µ⊥/ε. The plots of
µA vs. molecular area dependences are shown in Fig. 6.
Similarly to ∆V , the apparent dipole moment increases
upon film compression, reaching a maximum value (of
0.173 D) at molecular areas near the film collapse.
Fig. 6. Electric surface potential (∆V ) and apparent
dipole moment (µA) for erucylphosphocholine mono-
layer.
Using polarizing microscope the textures of the thin
layer of ErPC were observed. The substance was put
between two glass plates and observation of the textures
was done at heating and cooling (two scans) with the
rate of 5 K/min. First heating was from 25 ◦C to 100 ◦C
and cooling from 100 ◦C to −50 ◦C, afterwards the heat-
ing between −50 ◦C to 235 ◦C and cooling from 235 ◦C to
−100 ◦C were performed. During the first heating, the
first change of the texture has been registered at 63 ◦C
and the second one at 70 ◦C. It seems that the first one is
related to the transition between two crystalline phases
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(Cr1 and Cr2), while the second one corresponds to the
transition from crystal to nematic phase (N). The ne-
matic phase has been observed upon heating up to 100 ◦C
and on further cooling down to −0.5 ◦C when the tran-
sition to Cr2 has been observed. During further cooling,
the transition Cr2–Cr1 has been registered at −23.5 ◦C
and Cr1 has been visible up to −50 ◦C. The same phases
(Cr1, Cr2 and N) have been observed during second scan
of heating and cooling, and the nematic phase has been
detected up to 235 ◦C when the substance starts to cool
down. As an example, textures of Cr1, Cr2 and nematic
phases are presented in Fig. 7, both upon heating and
cooling.
Fig. 7. Textures observed during heating (a–d) and
cooling (e–f) at temperatures: −50 ◦C, Cr1 (a); 60 ◦C,
Cr2 (b); 70 ◦C, N (c); 235 ◦C, N (d); −30 ◦C, Cr1 (e);
−66 ◦C, Cr2 (f).
Fig. 8. DSC scans registered with rate of 10 K/min
for ErPC. Heating — dashed line, cooling — solid line;
ENDO — up, EXO — down.
DSC measurements were done in the same way as the
texture observation: first heating was performed from
room temperature up to 100 ◦C and then, after cool-
ing down to −50 ◦C, the sample was again heated up to
235 ◦C. Afterwards it was cooled down to −100 ◦C and
heated up again to 235 ◦C, then cooled to −100 ◦C and
next heated to the room temperature. The substance
was not heated above 235 ◦C to prevent thermal decom-
position of the sample.
Figure 8 presents the DSC curves obtained at heating
and cooling of the substance studied. As an example, the
third of three scans (heating and cooling) is shown. As
one can see, one doubled strong peak is visible on the
heating curves while on cooling one strong peak and two
small anomalies. The description of the recorded anoma-
lies was made on the basis of the above-mentioned tex-
ture observations. The transition temperatures as well as
transition enthalpies for each peak registered have been
calculated using Perkin Elmer Software. The results are
gathered in Table.
TABLE I
Transition temperatures and enthalpy changes calculated
from DSC measurements.
Peak Onset — transition
temperature [◦C]
Enthalpy change
[kJ/mol]
heating 1 15.2 13.2
2 21.4 19.0
cooling
3 7.9 29.3
4 −10.5 0.7
5 −19.3 0.4
As it is seen from Table, the transition temperatures
have been shifted towards lower temperatures during
cooling, which is typical for substances exhibiting liq-
uid crystalline properties. Based on DSC and texture
observation results, one can conclude that nematic liquid
crystalline phase exists during heating as well as cooling
of the sample.
4. Conclusions
Erucylphosphocholine is an excellent film-forming ma-
terial, suitable for the Langmuir monolayer investiga-
tions. The pi–A isotherms are hardly influenced by the
experimental conditions. Molecules of erucylphospho-
choline increase the surface potential of water (∆V values
are positive). DSC measurements revealed the presence
of nematic liquid crystalline phase upon heating and cool-
ing of the sample.
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